Moreover, the epidermal growth factor/Erb-B2 receptor tyrosine kinase 2 (EGF/ERBB2) signaling pathway in breast cancer cells modulated the transcription activity of ESRRA, which was associated with poor prognosis in breast and ovarian cancers32,34,35. This evidence concerns the gene ERBB2 and breast cancer.